[1] 杨丽华,刘晓丽,蒋雅琼,等. 我国痛风的患病率及危险因素[J]. 医学研究杂志, 2019, 48(12):4-6,10.
[2] 王荣, 汤哲, 孙菲, 等. 中国7城市老年人高尿酸血症患病率调查[J]. 中华流行病学杂志, 2018, 39(3):286-288.
[3] LI L J, ZHANG Y P, ZENG C C. Update on the epidemiology, genetics, and therapeutic options of hyperuricemia[J]. Am J Transl Res, 2020, 12(7):3167-3181.
[4] 赵文娟,刘丽君,李向红,等. 内蒙古地区成人高尿酸血症和痛风流行病学特征及其危险因素分析[J]. 应用预防医学, 2022, 28(5):421-425, 431.
[5] SCIRE C A, MANARA M, CIMMINO M A, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology(SIR)[J]. Arthritis Res Ther, 2013, 15(5):R101.
[6] FU T, CAO H, YIN R, et al. Associated factors with functional disability and health-related quality of life in Chinese patients with gout: a case-control study[J]. BMC Musculoskelet Disord, 2017, 18(1):429.
[7] 杨清雅,许超,杨亚旭,等. 肥胖与痛风的研究进展[J]. 风湿病与关节炎, 2023, 12(1):70-75.
[8] COHEN E, LEVI A, VECHT-LIFSHITZ S E, et al. Assessment of a possible link between hyperhomocysteinemia and hyperuricemia[J]. J Investig Med, 2015, 63(3):534-538.
[9] 谢丽玲,贺盼攀,秦献辉,等. 高尿酸血症治疗的研究进展[J]. 生物医学转化, 2021, 2(4):34-40.
[10] 梁晓峰.我国慢性病防控工作及展望[J]. 中国慢性病预防与控制, 2022, 30(6):408-409.
[11] 王俊,朱静敏,王雪瑶.医防融合的核心价值与实现机制[J]. 中国卫生, 2021,427(3):64-65.
[12] 黄叶飞,杨克虎,陈澍洪,等. 高尿酸血症/痛风患者实践指南[J]. 中华内科杂志, 2020, 59(7):519-527.
[13] 李秋霞,郝治行,康慧,等. 基层医疗慢性病健康管理中存在的问题及对策——以高尿酸血症/痛风为例[J]. 基层医学论坛, 2021, 25(29):4172-4175. |
